These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6104002)

  • 1. HAptoglobin, prostaglandins, and ductus arteriosus in preterm infants.
    Lucas A; Collier HO; Saeed SA; Mitchell MD
    Lancet; 1980 May; 1(8179):1186-7. PubMed ID: 6104002
    [No Abstract]   [Full Text] [Related]  

  • 2. Mass spectrometric determination of urinary prostaglandins in preterm infants. The basis for an effective and safe therapeutic regimen for the pharmacological closure.
    Seyberth HW; Müller H; Erlenmaier T; Mrongovius R
    Eur J Clin Pharmacol; 1980 Jul; 18(1):89-93. PubMed ID: 7398753
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostaglandins and the ductus arteriosus.
    Lancet; 1976 Oct; 2(7990):837. PubMed ID: 61506
    [No Abstract]   [Full Text] [Related]  

  • 4. Prediction of Therapeutic Response to Cyclooxygenase Inhibitors in Preterm Infants with Patent Ductus Arteriosus.
    Hu Y; Jin H; Jiang Y; Du J
    Pediatr Cardiol; 2018 Apr; 39(4):647-652. PubMed ID: 29468349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma-prostaglandins in pre-term neonates before and after treatment for patient ductus arteriosus.
    Lucas A; Mitchell MD
    Lancet; 1978 Jul; 2(8081):130-2. PubMed ID: 78327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic closure of patent ductus arteriosus in the premature infant.
    Friedman WF; Hirschklau MJ; Printz MP; Pitlick PT; Kirkpatrick SE
    N Engl J Med; 1976 Sep; 295(10):526-9. PubMed ID: 820994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminoglycoside treatment and renal prostaglandin excretion in premature infants.
    Kühl PG; Soeding K; Seyberth HW
    Dev Pharmacol Ther; 1985; 8(1):61-7. PubMed ID: 3857158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsurgical closure of patent ductus arteriosus in preterm infants.
    Smith ME
    Heart Lung; 1979; 8(2):308-10. PubMed ID: 253708
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of prostaglandins and prostaglandin inhibitors in critically ill neonates.
    Cohen MA
    MCN Am J Matern Child Nurs; 1983; 8(3):194-9. PubMed ID: 6405117
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prospects for the use of prostaglandins in pediatric cardiology].
    Zaorska B
    Kardiol Pol; 1981; 24(2):167-72. PubMed ID: 6788996
    [No Abstract]   [Full Text] [Related]  

  • 11. Breakthrough in treatment of patent ductus arteriosus.
    Lines DR
    Drugs; 1977 Jan; 13(1):1-2. PubMed ID: 832614
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacology of the ductus arteriosus.
    Dipalma JR
    Am Fam Physician; 1978 Jan; 17(1):194-5. PubMed ID: 414606
    [No Abstract]   [Full Text] [Related]  

  • 13. Patent ductus arteriosus. Clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment.
    Hammerman C
    Clin Perinatol; 1995 Jun; 22(2):457-79. PubMed ID: 7671547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of echocardiography to guide the duration of indomethacin treatment of patent ductus arteriosus in preterm infants.
    Bajaj R; Narasimhan R
    J Pediatr; 2010 Aug; 157(2):346; author reply 346. PubMed ID: 20553839
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical use of prostaglandins and prostaglandin synthetase inhibitors in cardiac problems of the newborn.
    Olley PM; Coceani F; Rowe RD; Swyer PR
    Adv Prostaglandin Thromboxane Res; 1980; 7():913-6. PubMed ID: 6768235
    [No Abstract]   [Full Text] [Related]  

  • 16. Patent ductus arteriosus: experimental aspects.
    Mott JC
    Arch Dis Child; 1980 Feb; 55(2):99-105. PubMed ID: 6769398
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostaglandins in patients ductus arteriosus.
    Lucas A; Mitchell MD
    Lancet; 1978 Oct; 2(8096):937-8. PubMed ID: 81944
    [No Abstract]   [Full Text] [Related]  

  • 18. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.
    Malviya M; Ohlsson A; Shah S
    Cochrane Database Syst Rev; 2003; (3):CD003951. PubMed ID: 12917997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of ibuprofen versus indomethacin for the treatment of patent ductus arteriosus in the preterm infant: reviewing the evidence.
    Donze A; Smith JR; Bryowsky K
    Neonatal Netw; 2007; 26(3):187-95. PubMed ID: 17521065
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants.
    Herrera C; Holberton J; Davis P
    Cochrane Database Syst Rev; 2004; (1):CD003480. PubMed ID: 14974018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.